Standout Papers

Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayes... 2022 2026 2023 2024168
  1. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection (2022)
    Sahil Khanna, Maha Assi et al. Drugs

Immediate Impact

11 by Nobel laureates 37 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
2023 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
4 intermediate papers

Works of Gary P. Wang being referenced

Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
2010
HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications
2007
and 3 more

Author Peers

Author Last Decade Papers Cites
Gary P. Wang 1692 859 557 716 47 2.9k
Brian C. Keller 1435 1102 619 408 45 3.4k
Tim Rostron 1138 707 485 263 27 2.5k
Kristine A. Kuhn 2055 566 533 473 68 4.3k
Filippo Canducci 1181 1115 827 311 79 3.4k
Ian McHardy 832 601 543 190 36 1.7k
R. Paul Wilson 1183 789 230 294 39 3.1k
Edith Porter 1636 402 619 554 64 4.7k
Thomas A. Brown 1807 268 416 986 78 4.5k
Thierry Jouault 1181 1752 1269 269 73 3.2k
Michael D. George 1621 832 1509 201 41 4.5k

All Works

Loading papers...

Rankless by CCL
2026